Loading clinical trials...
Loading clinical trials...
An Open Phase II Study to Assess the Efficacy and Safety of Topical SR-T100® Gel in the Treatment of Human Cutaneous Squamous Cell Carcinoma in Situ (Actinic Keratosis and Bowen's Disease)
Conditions
Interventions
SR-T100 ® Gel
Locations
1
Taiwan
National Cheng Kung University Hospital
Tainan, Taiwan
Start Date
November 1, 2007
Primary Completion Date
April 1, 2010
Completion Date
November 1, 2010
Last Updated
March 14, 2014
NCT06778434
NCT06648447
NCT05688904
NCT06888362
NCT07290959
NCT01820260
Lead Sponsor
G&E Herbal Biotechnology Co., LTD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions